📣 VC round data is live. Check it out!
- Public Comps
- Pague Menos
Pague Menos Valuation Multiples
Discover Pague Menos' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Farmacias Benavides, Cachet Pharmaceuticals, Genky Drug Stores, Zjamp Group and more.
Pague Menos Overview
About Pague Menos
Empreendimentos Pague Menos SA operates a pharmacy chain in Brazil. It engaged in the retail trade of medicines, perfumes, personal hygiene, and beauty products. It revenues arises mainly from the sale of medicines, perfumes, and several self-service products to the end consumer.
Founded
1981
HQ

Employees
N/A
Website
Sectors
Financials (LTM)
EV
$1B
Valuation Multiples
Start free trialPague Menos Financials
Pague Menos reported last 12-month revenue of $3B and EBITDA of $210M.
In the same LTM period, Pague Menos generated $970M in gross profit, $210M in EBITDA, and $62M in net income.
Revenue (LTM)
Pague Menos P&L
In the most recent fiscal year, Pague Menos reported revenue of $3B and EBITDA of $239M.
Pague Menos is profitable as of last fiscal year, with gross margin of 32%, EBITDA margin of 8%, and net margin of 2%.
Financial data powered by Morningstar, Inc.
Pague Menos Stock Performance
Pague Menos has current market cap of $611M, and enterprise value of $1B.
Market Cap Evolution
Pague Menos' stock price is $0.85.
Pague Menos share price decreased by 0.1% in the last 30 days, and increased by 28.0% in the last year.
Pague Menos has an EPS (earnings per share) of $0.07.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $611M | -0.1% | -0.1% | -31.9% | 28.0% | $0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPague Menos Valuation Multiples
Pague Menos trades at 0.4x EV/Revenue multiple, and 6.1x EV/EBITDA.
EV / Revenue (LTM)
Pague Menos Financial Valuation Multiples
As of June 2, 2026, Pague Menos has market cap of $611M and EV of $1B.
Pague Menos has a P/E ratio of 9.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Pague Menos Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Pague Menos Margins & Growth Rates
Pague Menos grew revenue by 13% but EBITDA decreased by 2% in the last fiscal year.
In the most recent fiscal year, Pague Menos reported gross margin of 32%, EBITDA margin of 8%, and net margin of 2%.
Pague Menos Margins
Pague Menos Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Pague Menos Operational KPIs
Pague Menos' Rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Pague Menos' Rule of X is 38% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Pague Menos Competitors
Pague Menos competitors include Farmacias Benavides, Cachet Pharmaceuticals, Genky Drug Stores, Zjamp Group, Luyan Pharma, Cawachi, DocMorris, JZJ Chain Drugstore, Apotea and Dimed SA.
Most Pague Menos public comparables operate across Pharmacies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.8x | - | 7.3x | - | |||
| 0.2x | - | 8.0x | - | |||
| 0.6x | 0.6x | 7.3x | 7.1x | |||
| 0.0x | - | 0.7x | - | |||
| 0.4x | - | 13.5x | - | |||
| 0.2x | 0.2x | 4.6x | - | |||
| 0.4x | 0.4x | (11.4x) | (11.5x) | |||
| 0.7x | - | 5.6x | - | |||
This data is available for Pro users. Sign up to see all Pague Menos competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Pague Menos
Pague Menos has acquired 1 company to date.
Last acquisition by Pague Menos was on May 18th 2021. Pague Menos acquired Extrafarma for $119M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Pague Menos
| Description | Extrafarma is a Belém-headquartered pharmacy chain operating 416 stores across 11 Brazilian states including Pará, Maranhão, and Amapá. Established in 1998 through mergers, it leads retail pharmacy sales in northern Brazil with private-label generics and beauty products. The network employs 10,000 staff and partners with wholesalers for nationwide distribution. |
| HQ Country | |
| HQ City | Belém |
| Deal Date | 18 May 2021 |
| Valuation | $119M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Pague Menos acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Pague Menos
| When was Pague Menos founded? | Pague Menos was founded in 1981. |
| Where is Pague Menos headquartered? | Pague Menos is headquartered in Brazil. |
| Is Pague Menos publicly listed? | Yes, Pague Menos is a public company listed on B3. |
| What is the stock symbol of Pague Menos? | Pague Menos trades under PGMN3 ticker. |
| When did Pague Menos go public? | Pague Menos went public in 2020. |
| Who are competitors of Pague Menos? | Pague Menos main competitors include Farmacias Benavides, Cachet Pharmaceuticals, Genky Drug Stores, Zjamp Group, Luyan Pharma, Cawachi, DocMorris, JZJ Chain Drugstore, Apotea, Dimed SA. |
| What is the current market cap of Pague Menos? | Pague Menos' current market cap is $611M. |
| What is the current revenue of Pague Menos? | Pague Menos' last 12 months revenue is $3B. |
| What is the current revenue growth of Pague Menos? | Pague Menos revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of Pague Menos? | Current revenue multiple of Pague Menos is 0.4x. |
| What is the current EBITDA of Pague Menos? | Pague Menos' last 12 months EBITDA is $210M. |
| What is Pague Menos' EBITDA margin? | Pague Menos' last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of Pague Menos? | Current EBITDA multiple of Pague Menos is 6.1x. |
| What is the current FCF of Pague Menos? | Pague Menos' last 12 months FCF is $11M. |
| What is Pague Menos' FCF margin? | Pague Menos' last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of Pague Menos? | Current FCF multiple of Pague Menos is 112.1x. |
| How many companies Pague Menos has acquired to date? | As of June 2026, Pague Menos has acquired 1 company. |
| What was the largest acquisition by Pague Menos? | $119M acquisition of Extrafarma on 18th May 2021 was the largest M&A Pague Menos has done to date. |
| What companies Pague Menos acquired? | Pague Menos acquired Extrafarma. |
| In how many companies Pague Menos has invested to date? | Pague Menos hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Pague Menos
Lists including Pague Menos
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
